We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$136M |
| 2 |
Tesla
TSLA
|
+$119M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
Home Depot
HD
|
+$101M |
| 5 |
Pfizer
PFE
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$247M |
| 2 |
Intel
INTC
|
+$216M |
| 3 |
Ford
F
|
+$145M |
| 4 |
General Motors
GM
|
+$143M |
| 5 |
Micron Technology
MU
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Robinhood
HOOD
$82.5B
| $174K | ﹤0.01% |
+9,840
| New | +$303K |
|
|
RETA
1952
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $174K | ﹤0.01% |
+6,580
| New | +$509K |
|
|
APPH
1953
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $174K | ﹤0.01% |
+44,650
| New | +$239K |
|
1954
Tactile Systems Technology
TCMD
$631M
| $173K | ﹤0.01% |
9,080
-8,020
| -47% | -$227K |
|
|
LYRA
1955
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $171K | ﹤0.01% |
783
| – | – |
|
|
BRKL
1956
DELISTED
Brookline Bancorp
BRKL
| $170K | ﹤0.01% |
10,530
-15,470
| -60% | -$247K |
|
1957
Ranpak Holdings
PACK
$572M
| $169K | ﹤0.01% |
+4,500
| New | +$159K |
|
1958
Rocket Pharmaceuticals
RCKT
$355M
| $169K | ﹤0.01% |
+7,730
| New | +$211K |
|
1959
Bristow Group
VTOL
$1.37B
| $169K | ﹤0.01% |
5,326
-8,030
| -60% | -$271K |
|
|
ZYXI
1960
DELISTED
Zynex
ZYXI
| $169K | ﹤0.01% |
18,700
| – | – |
|
1961
ACM Research
ACMR
$5.12B
| $168K | ﹤0.01% |
+5,910
| New | +$187K |
|
1962
Brookdale Senior Living
BKD
$3.72B
| $168K | ﹤0.01% |
+32,530
| New | +$203K |
|
1963
B2Gold
BTG
$5.08B
| $168K | ﹤0.01% |
42,500
+7,200
| +20% | +$28.9K |
|
1964
Oscar Health
OSCR
$8.5B
| $168K | ﹤0.01% |
+21,460
| New | +$269K |
|
1965
PAR Technology
PAR
$709M
| $167K | ﹤0.01% |
+3,160
| New | +$190K |
|
|
TWOU
1966
DELISTED
2U Inc
TWOU
| $166K | ﹤0.01% |
+276
| New | +$220K |
|
1967
Morningstar
MORN
$7.05B
| $164K | ﹤0.01% |
+480
| New | +$149K |
|
1968
Future Fuel
FF
$205M
| $163K | ﹤0.01% |
21,309
-1,490
| -7% | -$11.6K |
|
1969
Safety Insurance
SAFT
$1.52B
| $162K | ﹤0.01% |
1,900
| – | – |
|
|
DQ
1970
Daqo New Energy
DQ
$805M
| $161K | ﹤0.01% |
4,000
| – | – |
|
1971
Aclaris Therapeutics
ACRS
$744M
| $160K | ﹤0.01% |
+10,970
| New | +$166K |
|
1972
Orthofix Medical
OFIX
$491M
| $160K | ﹤0.01% |
5,150
-2,650
| -34% | -$88.6K |
|
1973
Kanzhun
BZ
$6.94B
| $159K | ﹤0.01% |
+4,500
| New | +$158K |
|
1974
Gogo Inc
GOGO
$534M
| $159K | ﹤0.01% |
+11,720
| New | +$174K |
|
|
AUY
1975
DELISTED
Yamana Gold, Inc.
AUY
| $158K | ﹤0.01% |
37,528
+6,100
| +19% | +$25.3K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
- Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
- Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
- Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
- Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
- Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
- Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.